Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver 3 Days of Expert-Led Content to Advance Autoimmune TCE Strategy

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)

Read more

Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies

Read more

Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics

Read more

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Read more

Calquence approved in China for chronic lymphocytic leukaemia

Read more

GSK’s regulatory submission accepted for review by Japanese regulator for use of Nucala (mepolizumab) in adults with chronic rhinosinusitis with nasal polyps

Read more

AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

Read more

7th IPF Summit: Advancing Insights and Collaboration in Pulmonary Fibrosis Research and Therapeutic Development

Read more

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

Read more

Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases

Read more

Posts pagination

Previous Page 1 of 946 … Page 173 of 946 … Page 946 of 946 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version